Anaphylaxis
MONDO:0100053An acute hypersensitivity reaction that occurs from exposure to an allergen. It results from the release of histamine and histamine-like substances from mast cells, and can present with breathing difficulty due to narrowed airways, dizziness and hypotension, skin rash, weak pulse, nausea and vomiting.
Also known as: anaphylactic shock, systemic anaphylaxis
29 clinical trials for this condition and its sub-types, 26 tagged with Anaphylaxis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Anaphylaxis
-
Idiopathic anaphylaxis 1 trial
-
Exercise-induced anaphylaxis 0 trials · 1 incl. sub-types
1 sub-type
-
Can a new injection tame wheat allergy?
Disease control Not yet recruitingResearchers are testing an experimental injectable drug called LP-003 in people with wheat allergy that triggers allergic reactions during exercise. The Phase II trial enrolls 12 participants aged 12 to 60 who have a history of wheat or gluten allergy and react to a small amount …
Phase 2 • Sponsor: Longbio Pharma (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
AI tool aims to cut allergy misdiagnosis in primary care
Diagnosis Not yet recruitingThis study tests whether AI-powered decision trees can help general practitioners better diagnose and manage allergies. About 600 patients with suspected allergies will be enrolled, and doctors will use an app that suggests next steps based on symptoms. The goal is to see if this…
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Can mapping fish allergy profiles in kids improve diagnosis?
Knowledge-focused Not yet recruitingThis study follows 120 children and adolescents in Spain who have been newly diagnosed with IgE-mediated fish allergy. Researchers will collect data on symptoms, test results, and molecular sensitization patterns to better understand how fish allergy presents in this population. …
Sponsor: Carmelo Escudero • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
LUMISIGHT allergy risk under the microscope in 1,500 patients
Knowledge-focused Not yet recruitingThis study monitors 1,500 adults with breast cancer who receive LUMISIGHT during lumpectomy surgery. Researchers will track how often serious allergic reactions occur within 60 minutes of injection. No new drug is being tested; the goal is to better understand the safety of this …
Sponsor: Lumicell, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC